Cataracts

A cataract is a clouding or opacity of the lens that impairs light transmission to the retina, resulting in progressive vision loss. Cataracts represent the leading cause of blindness worldwide and the most common cause of vision loss in patients over 60 years of age in developed nations. The prevalence increases dramatically with age, affecting approximately 50% of individuals by age 80, though secondary cataracts can develop at any age in susceptible populations. Clinically significant cataracts account for over 20 million cases annually globally and represent a major indication for surgical intervention in ophthalmology. Understanding cataract pathophysiology, risk stratification, and surgical indications is essential for primary care physicians and internal medicine practitioners who frequently encounter these patients and must counsel them regarding timing of intervention and visual rehabilitation.

Cataracts develop through a complex interplay of lens biochemistry, protein aggregation, and oxidative stress mechanisms that progressively opacify the normally transparent lens:

- Oxidative Damage and Free Radical Accumulation: The lens is particularly vulnerable to oxidative stress due to its constant exposure to ultraviolet (UV) radiation and its limited capacity for cellular turnover and protein synthesis. Reactive oxygen species (ROS) generated from mitochondrial metabolism, UV exposure, and metabolic byproducts accumulate over time and overwhelm the lens's antioxidant defense systems (catalase, superoxide dismutase, glutathione peroxidase, and reduced glutathione). This oxidative stress causes lipid peroxidation of the lens cell membranes, protein cross-linking, and glycation of lens proteins. The aqueous humor provides some protection through antioxidants like ascorbate and taurine, but this protection diminishes with age as the anterior chamber becomes more compartmentalized. ROS-induced damage to both lens epithelial cells and mature lens fibers initiates a cascade of protein denaturation and aggregation.

- Protein Cross-Linking and Aggregation: The lens is composed of about 90% protein by dry weight, predominantly α-, β-, and γ-crystallins, which are synthesized during embryonic development and persist throughout life without replacement. With aging and oxidative damage, these crystallin proteins undergo extensive post-translational modifications including disulfide bond formation, glycation (non-enzymatic glycosylation on lysine and arginine residues), and advanced glycation end-product (AGE) formation. These modifications cause proteins to progressively aggregate and cross-link, forming insoluble complexes that scatter light. The process is particularly accelerated in diabetes, where hyperglycemia dramatically increases protein glycation rates. Protein aggregation increases lens density and refractive index heterogeneity, which scatters light and reduces its transmission to the retina. The accumulation of high-molecular-weight protein aggregates increases lens stiffness and contributes to presbyopia in addition to opacity.

- Osmotic Imbalance and Water Influx: The lens maintains its clarity through precise osmotic homeostasis. Cataracts disrupt this balance through multiple mechanisms. In cortical cataracts, protein denaturation exposes hydrophobic amino acid residues that were previously buried, leading to increased hydration and water influx into lens fibers. This causes fiber swelling and disruption of the highly organized crystalline architecture. Additionally, mitochondrial dysfunction in lens epithelial cells impairs the Na⁺/K⁺-ATPase pump, leading to sodium accumulation and further osmotic water influx. In nuclear cataracts, protein cross-linking increases lens density, and the accumulated non-refractive proteins reduce the refractive index difference between lens compartments, increasing light scatter. The loss of lens fiber organization and the accumulation of unfolded proteins create inhomogeneous refractive properties that disrupt the precise optical focusing required for clear vision.

- Glutathione Depletion and Antioxidant Failure: The lens relies heavily on reduced glutathione (GSH) as its primary antioxidant defense against oxidative stress. Glutathione maintains lens protein thiols in their reduced state, preventing inappropriate cross-linking. With aging and chronic oxidative stress, glutathione becomes depleted through oxidation to oxidized glutathione (GSSG) and consumption during detoxification reactions. The lens has limited capacity to regenerate glutathione due to its lack of vascularity and reliance on anaerobic glycolysis. The glutathione redox system failure allows accumulation of oxidized protein residues and abnormal disulfide bonds between crystallins, leading to irreversible protein aggregation. This mechanism explains why antioxidant supplementation (vitamin C, vitamin E, carotenoids) shows modest benefit if given early enough to maintain glutathione homeostasis.

- Metabolic Derangements in Secondary Cataracts: In conditions like diabetes, abnormal carbohydrate metabolism generates additional pathogenic pathways. The polyol pathway becomes activated in the presence of elevated glucose, whereby aldose reductase catalyzes the conversion of glucose to sorbitol, and sorbitol dehydrogenase converts sorbitol to fructose. Sorbitol accumulation creates osmotic stress and activates protein kinase C, triggering inflammatory pathways. Additionally, hyperglycemia promotes non-enzymatic glycation of lens crystallins at an accelerated rate, causing AGE cross-linking. In galactosemia, galactose is metabolized to galactitol via the polyol pathway, causing severe osmotic imbalance and osmotic cataracts. In Wilson disease, copper accumulation in the lens epithelium causes a characteristic greenish-brown Kayser-Fleischer ring-like appearance and anterior lens opacities.

Cataracts result from diverse etiologies that can be categorized by age of onset, pathophysiology, and association with systemic disease:

- Age-Related (Nuclear Sclerotic) Cataracts: Representing 90% of cataracts in developed nations, age-related cataracts develop through accumulated oxidative damage, protein cross-linking, and the natural aging process of the lens. The risk increases exponentially after age 60, with prevalence approaching 50% by age 80 and nearly universal prevalence by age 90. The nuclear region of the lens becomes progressively dense and yellow-brown, with initial changes visible by slit lamp as nuclear opalescence or sclerosis. The molecular basis involves decades of cumulative oxidative stress, progressive glutathione depletion, and cross-linking of α- and β-crystallins. Genetic polymorphisms affecting antioxidant capacity (SOD2 polymorphisms, glutathione S-transferase variants) influence individual susceptibility to age-related cataracts.

- Ultraviolet (UV) Radiation Exposure: Chronic UV-B exposure is the second major risk factor for age-related cataracts and accounts for approximately 10-15% of attributable cataract risk globally. UV radiation directly damages lens proteins through photochemical reactions and indirectly generates ROS through photosensitization mechanisms. Individuals with lifetime high UV exposure (outdoor workers, individuals near the equator, those with fair skin and light eyes) have a 3-6 fold increased risk of cortical cataracts. The dose-response relationship is well-established, with each 10-year increase in estimated UV exposure associated with approximately 10% increased cataract prevalence. UV-protective measures including broad-spectrum sunglasses and wide-brimmed hats reduce cataract risk and are particularly important in pediatric populations with susceptible lenses.

- Diabetes Mellitus: Diabetes increases cataract risk 2-5 fold compared to non-diabetic populations, with risk proportional to glycemic control duration and severity. Type 1 diabetes carries the highest risk, with diabetic cataracts developing decades earlier than age-matched controls. The osmotic pathway through aldose reductase and sorbitol accumulation plays a major role, particularly in rapid-onset cataracts occurring in young patients with new-onset hyperglycemia. Additionally, hyperglycemia accelerates protein glycation and AGE formation, enhances oxidative stress through increased glucose autoxidation, and causes mitochondrial dysfunction in lens epithelial cells. Diabetic patients frequently develop cortical or subcapsular cataracts, though all morphologic types occur. Intensive glycemic control has been shown to slow cataract progression rate in both Type 1 and Type 2 diabetes.

- Corticosteroid Use: Systemic corticosteroid exposure causes posterior subcapsular cataracts (PSC) through poorly understood mechanisms potentially involving altered lens epithelial cell metabolism, increased protein synthesis, or alterations in lens membrane permeability. The risk is dose- and duration-dependent, with significant risk emerging after cumulative doses exceeding 5-10 mg prednisone daily for >1 year. Young patients receiving prolonged corticosteroids (for inflammatory bowel disease, connective tissue disease, autoimmune conditions, or post-transplantation) are particularly susceptible. Even inhaled corticosteroids at high doses carry increased cataract risk. Topical ocular corticosteroids applied to the eye can also cause cataracts with prolonged use. The onset may be reversible if detected early and corticosteroids are discontinued, but established cataracts typically progress despite cessation of corticosteroid therapy.

- Congenital and Developmental Causes: Cataracts present at birth or in early childhood may result from genetic mutations (autosomal dominant mutations in crystallin genes like GJA8, CRYA, CRYB, and GJA3 account for ~50% of hereditary cataracts), intrauterine infections (TORCH infections—Toxoplasma, Rubella, CMV, Herpes simplex), metabolic disorders (galactosemia, Lowe syndrome, Marfan syndrome, Alport syndrome), or maternal factors during pregnancy. Intrauterine rubella infection is the classic association with congenital cataracts ("salt and pepper" appearance), though this has become rare in vaccinated populations. Galactosemia presents with neonatal cataracts ("oil droplet" appearance) that may be reversible if galactose-restricted diet is started early. Genetic counseling and early surgical intervention are important for preventing amblyopia in congenital cataracts.

- Myotonic Dystrophy: Patients with myotonic dystrophy frequently develop characteristic posterior subcapsular and iridescent cataracts that show a distinctive "rainbow" appearance under slit lamp examination. These cataracts develop in the third to fourth decade and may precede symptomatic muscle disease. The cataracts in myotonic dystrophy are believed to result from abnormal lens epithelial cell function related to myotonin-protein kinase dysfunction. The presence of cataracts in a young patient with proximal weakness should prompt evaluation for myotonic dystrophy and genetic testing.

- Hypoparathyroidism and Hypocalcemia: Chronic hypocalcemia from any cause (hypoparathyroidism, pseudohypoparathyroidism, vitamin D deficiency) can precipitate anterior subcapsular cataracts. The mechanism involves calcium-dependent processes in lens epithelial cells, with chronic hypocalcemia leading to altered lens epithelial function and protein aggregation. These cataracts may show a characteristic "bread crumb" or granular appearance and develop relatively rapidly compared to age-related cataracts. Correction of calcium levels may halt progression but does not reverse established cataracts.

- Other Systemic Associations: Chronic renal failure causing secondary hyperparathyroidism, chronic liver disease, and severe malnutrition have all been associated with increased cataract formation. Atopic dermatitis, when severe, is associated with anterior subcapsular cataracts ("atopic cataracts"). Ocular trauma causing lens capsule violation leads to traumatic cataracts through direct protein denaturation and oxidative damage. Chronic uveitis from any cause increases cataract risk through inflammatory mediators and cytokine damage. Retinitis pigmentosa and other inherited retinal disorders frequently develop associated cataracts.

- Medications: Beyond corticosteroids, several medications are associated with increased cataract risk. Amiodarone causes microdeposits visible on slit lamp but not typically visually significant cataracts. Phenothiazines, particularly chlorpromazine at high cumulative doses, cause anterior subcapsular opacities. Tamsulosin and other alpha-blockers may increase intraoperative cataract complications but do not cause cataracts. Tobacco smoking increases age-related cataract risk by approximately 2-3 fold and appears to work through oxidative stress mechanisms.

Cataracts present with a spectrum of visual symptoms related to the location, density, and progression of lens opacification:

- Progressive Painless Vision Loss: The hallmark symptom is gradual, painless decline in visual acuity that may develop over months to years in age-related cases or weeks to months in secondary cataracts like those associated with diabetes or corticosteroid use. Patients typically describe difficulty with reading, watching television, or driving, particularly in the early morning when the pupil is most constricted. The vision loss is non-specific and painless, which distinguishes it from acute vision loss from retinal or vascular causes. Unlike retinal pathology, the visual field remains intact, though the overall image clarity is reduced. The rate of progression varies widely among individuals and even between eyes of the same individual.

- Glare and Photopsia: Patients frequently complain of increased glare, particularly when exposed to bright light, headlights while driving, or sunlight. This occurs because lens opacities scatter light within the eye, with scattered light perceived as glare superimposed on the central image. Patients may report that their vision is better on cloudy days or indoors and worse in bright sunlight. This glare becomes particularly problematic when driving, making nighttime driving dangerous even when distance visual acuity measures only mildly reduced. Photopsia or seeing haloes around light sources can occur due to the scattering effects of lens opacities.

- Monocular Diplopia: Some patients report that they see double images in one eye only (monocular diplopia), a pathognomonic finding indicating cataract rather than retinal or neurological causes. This occurs when the developing cataract creates opacities that split the light path in the eye, creating multiple images on the retina. This symptom typically resolves as the cataract progresses and becomes more homogeneous. Testing monocular diplopia by covering the opposite eye confirms it is monocular rather than binocular.

- Changes in Color Perception: In nuclear sclerotic cataracts, the lens becomes progressively yellow and brown due to accumulation of yellow pigments (tryptophan metabolites, proteasome products, and AGEs). This yellow tint causes a shift in perceived colors, with patients reporting that whites appear yellowish and blues and purples become difficult to distinguish. This "brunescence" can be profound in advanced cataracts, occasionally creating a dramatic shift in color perception. Some patients report a temporary improvement in near vision (**second sight**) as the denser nuclear lens changes the refractive power of the eye, creating increased myopia that may temporarily eliminate presbyopia before progressive myopia makes vision worse overall.

- "Second Sight" (Lenticular Myopia): A notable clinical phenomenon is the temporary improvement in near vision that may occur early in nuclear sclerotic cataract formation. As the nuclear lens becomes progressively denser, its refractive power increases, shifting the eye toward myopia and temporarily allowing near vision without reading glasses in previously presbyopic individuals. This usually lasts only a few months before progressive opacity and increasing myopia worsen overall vision. This phenomenon is often brought to the attention of patients' primary care physicians, who should recognize it as a classic sign of developing nuclear sclerotic cataract and refer for ophthalmology evaluation.

- Decreased Contrast Sensitivity: Patients often report difficulty distinguishing objects against background, such as seeing a curb against the sidewalk, or difficulty recognizing faces. This decreased contrast sensitivity results from light scatter and glare caused by the opacities and is often more functionally limiting than the measured reduction in visual acuity. Contrast sensitivity testing is more sensitive than standard visual acuity in detecting early cataracts and correlates better with functional disability.

- Physical Exam Findings - Slit Lamp Findings: On slit lamp examination, various morphologic types of cataracts can be identified: Nuclear sclerotic cataracts show a brown or amber discoloration in the central nucleus with progression from clear nucleus to opalescence to brunescence. Cortical cataracts appear as white opacities radiating from the nucleus like spokes in a wheel, initially visible at the periphery and progressing toward the center. Posterior subcapsular cataracts show granular or bread-crumb-like opacities in the posterior cortex just anterior to the posterior lens capsule and are particularly prominent when viewing through the pupil. Anterior subcapsular cataracts appear as opacities immediately behind the anterior lens capsule and are visible when viewing from the pupil direction.

- Reduced Red Reflex: The red reflex, normally a bright red-orange reflection visible when examining with an ophthalmoscope from approximately 15 cm, becomes dimmed, interrupted, or absent depending on cataract density. A cataracts causes dark spots or sectors within the red reflex (a "hole" in the red reflex). The degree of red reflex reduction correlates with cataract density and can be assessed on primary care examination to document severity. Complete absence of the red reflex raises concern for corneal opacity, vitreous pathology, or retinal disease in addition to cataract.

**- Important Clinical Variants -

Cataract is a clinical, structural diagnosis — the goal of testing is to confirm lens opacity, quantify functional impairment, and exclude a competing cause of vision loss before attributing it to the lens.

There is no laboratory test for cataract; labs are directed at the underlying cause (glucose/HbA1c, calcium and PTH, galactosemia screening, TORCH serologies in infants).

Urgent situations first: a mature or intumescent lens causing phacomorphic angle closure or phacolytic glaucoma is an ocular emergency — lower intraocular pressure medically (topical beta blocker such as timolol, alpha-2 agonist, carbonic anhydrase inhibitor, ± systemic acetazolamide or mannitol) and arrange urgent lens extraction. In infants, a visually significant congenital cataract must be removed within the first weeks to months of life; delay causes irreversible deprivation amblyopia.